Susquehanna International Group’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-337
| Closed | -$28.6K | – | 6413 |
|
|
2024
Q4 | $28.6K | Buy |
337
+244
| +262% | +$20.7K | ﹤0.01% | 5961 |
|
|
2024
Q3 | $17.2K | Buy |
93
+11
| +13% | +$2.04K | ﹤0.01% | 5424 |
|
|
2024
Q2 | $14.1K | Hold |
82
| – | – | ﹤0.01% | 5441 |
|
|
2024
Q1 | $35.3K | Sell |
82
-333
| -80% | -$144K | ﹤0.01% | 5215 |
|
|
2023
Q4 | $365K | Buy |
415
+68
| +20% | +$59.7K | ﹤0.01% | 4289 |
|
|
2023
Q3 | $325K | Buy |
347
+221
| +175% | +$207K | ﹤0.01% | 3964 |
|
|
2023
Q2 | $121K | Sell |
126
-78
| -38% | -$75K | ﹤0.01% | 4919 |
|
|
2023
Q1 | $228K | Buy |
+204
| New | +$228K | ﹤0.01% | 4721 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5847 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6126 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5809 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5747 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5827 |
|